176 related articles for article (PubMed ID: 23116193)
1. Anti-Candida albicans effectiveness of citral and investigation of mode of action.
Lima IO; de Medeiros Nóbrega F; de Oliveira WA; de Oliveira Lima E; Albuquerque Menezes E; Cunha FA; Formiga Melo Diniz Mde F
Pharm Biol; 2012 Dec; 50(12):1536-41. PubMed ID: 23116193
[TBL] [Abstract][Full Text] [Related]
2. Investigating the antifungal activity and mechanism(s) of geraniol against Candida albicans strains.
Leite MC; de Brito Bezerra AP; de Sousa JP; de Oliveira Lima E
Med Mycol; 2015 Apr; 53(3):275-84. PubMed ID: 25480017
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Antifungal Activity and Mechanism of Action of Citral against Candida albicans.
Leite MC; Bezerra AP; de Sousa JP; Guerra FQ; Lima Ede O
Evid Based Complement Alternat Med; 2014; 2014():378280. PubMed ID: 25250053
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp.
Peixoto LR; Rosalen PL; Ferreira GL; Freires IA; de Carvalho FG; Castellano LR; de Castro RD
Arch Oral Biol; 2017 Jan; 73():179-185. PubMed ID: 27771586
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
Vardar-Unlu G; Yağmuroğlu A; Unlu M
Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of geraniol and citronellol, two monoterpenes alcohols, against Trichophyton rubrum involves inhibition of ergosterol biosynthesis.
Pereira Fde O; Mendes JM; Lima IO; Mota KS; Oliveira WA; Lima Ede O
Pharm Biol; 2015 Feb; 53(2):228-34. PubMed ID: 25414073
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
8. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Yüksekkaya S; Fındık D; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
[TBL] [Abstract][Full Text] [Related]
9. Mode of action and synergistic effect of valinomycin and cereulide with amphotericin B against Candida albicans and Cryptococcus albidus.
Makarasen A; Reukngam N; Khlaychan P; Chuysinuan P; Isobe M; Techasakul S
J Mycol Med; 2018 Mar; 28(1):112-121. PubMed ID: 29276078
[TBL] [Abstract][Full Text] [Related]
10. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Zore GB; Thakre AD; Jadhav S; Karuppayil SM
Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
[TBL] [Abstract][Full Text] [Related]
11. Antifungal Activity, Mode of Action, Docking Prediction and Anti-biofilm Effects of (+)-β-pinene Enantiomers against Candida spp.
de Macêdo Andrade AC; Rosalen PL; Freires IA; Scotti L; Scotti MT; Aquino SG; de Castro RD
Curr Top Med Chem; 2018; 18(29):2481-2490. PubMed ID: 30430938
[TBL] [Abstract][Full Text] [Related]
12. Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B.
O'Keeffe J; Doyle S; Kavanagh K
J Pharm Pharmacol; 2003 Dec; 55(12):1629-33. PubMed ID: 14738588
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
Paniagua GL; Monroy E; Negrete E; Vaca S
Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
[TBL] [Abstract][Full Text] [Related]
14. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
15. Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B.
Geraghty P; Kavanagh K
Arch Microbiol; 2003 Apr; 179(4):295-300. PubMed ID: 12640519
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
Sardari S; Mori Y; Kurosawa T; Daneshtalab M
Can J Microbiol; 2003 May; 49(5):344-9. PubMed ID: 12897828
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the antifungal activity of carvacrol against strains of Cryptococcus neoformans.
Nóbrega RO; Teixeira AP; Oliveira WA; Lima EO; Lima IO
Pharm Biol; 2016 Nov; 54(11):2591-2596. PubMed ID: 27225838
[TBL] [Abstract][Full Text] [Related]
20. The possible mechanism of rhapontigenin influencing antifungal activity on Candida albicans.
Kim N; Kim JK; Hwang D; Lim YH
Med Mycol; 2013 Jan; 51(1):45-52. PubMed ID: 22662760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
